Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
28.06
-0.07 (-0.25%)
Jul 28, 2026, 2:52 PM EDT - Market open
Lakefront Biotherapeutics NV Employees
Lakefront Biotherapeutics NV had 452 employees as of December 31, 2025. The number of employees decreased by 252 or -35.80% compared to the previous year.
Employees
452
Change
-252
Growth
-35.80%
Revenue / Employee
$2,662,500
Profits / Employee
$1,246,823
Market Cap
1.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 452 | -252 | -35.80% |
| Jun 30, 2025 | 558 | - | - |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Sep 30, 2022 | 1,357 | 38 | 2.88% |
| Mar 31, 2022 | 1,305 | -23 | -1.73% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Sep 30, 2021 | 1,319 | -88 | -6.25% |
| Jun 30, 2021 | 1,397 | 267 | 23.63% |
| Mar 31, 2021 | 1,328 | 198 | 17.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immunocore Holdings | 524 |
| Ocular Therapeutix | 325 |
| Syndax Pharmaceuticals | 298 |
| Kardigan | 241 |
| Stoke Therapeutics | 170 |
| Bicara Therapeutics | 103 |
| Taysha Gene Therapies | 99 |
LKFT News
- 6 days ago - Acquisition of Own Shares - GlobeNewsWire
- 13 days ago - Acquisition of Own Shares - GlobeNewsWire
- 14 days ago - Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi - GlobeNewsWire
- 18 days ago - Lakefront Biotherapeutics resumed with an Equal Weight at Morgan Stanley - TheFly
- 4 weeks ago - Lakefront Receives Transparency Notification from Madison Avenue Partners - GlobeNewsWire
- 6 weeks ago - Lakefront Biotherapeutics announces EUR 50M share repurchase program - TheFly
- 6 weeks ago - Lakefront Announces Initiation of €50 Million Stock Repurchase Program - GlobeNewsWire
- 7 weeks ago - Lakefront Biotherapeutics appoints Eric Hedrick chief medical officer - TheFly